Brooks et al. [54] found that circadian rhythm-related lncRNA ADIRF-AS1 drove clear cell renal carcinoma progression through targeting PBAF; Zhang et al. [55] constructed a model of circadian rhythm-associated lncRNAs that stably predicted the prognosis of hepatocellular carcinoma with a significant impact to the immune infiltration status of the tumor; Liu et al. [56] constructed a circadian rhythm-associated gene risk model to predict survivals in patients with melanoma, non-small-cell lung cancer, and glioma, and could differentiate the immune cell infiltration status in these patients. Here, ADIRF is linked to non-small cell lung carcinoma.